What Is Non-Surgical Spinal Decompression Therapy? How the DRX9000® Works

For patients told they have a herniated disc, sciatica, or degenerative disc disease, the next question is usually what treatments exist that are not surgery. A herniated disc does not have to mean surgery, and non-surgical spinal decompression is one of the most studied answers. The FDA-cleared DRX9000 system is the device that defines the category. The treatment is not magic, not a quick fix, and not appropriate for every case.

It is a specific clinical protocol with specific indications, specific contraindications, and specific evidence behind it. This guide walks through what the treatment actually is, how it works mechanically, what a typical session looks like, and how to know if you are a candidate before scheduling.

Non-surgical spinal decompression therapy uses a computerized table to gently stretch the spine and create negative pressure within disc spaces. The FDA-cleared DRX9000 system holds 510(k) clearance for chronic low back pain and sciatica caused by lumbar herniated discs, bulging discs, and degenerative disc disease. Treatment typically runs 20 to 28 sessions over six to eight weeks.

Non-surgical spinal decompression therapy is a computer-controlled traction protocol that gently elongates the spine to reduce pressure on intervertebral discs and nerve roots. The treatment is delivered on FDA-cleared equipment like the DRX9000, which uses servo-motor technology to apply precise, sustained forces at angles targeted to specific spinal levels.

The therapy is non-surgical because it requires no incisions, no anesthesia, and no recovery time between sessions. It is decompression because the goal is to reverse the compressive forces that produced the disc problem in the first place. Standing, sitting, lifting, and gravity all compress the spine across a normal day. Decompression therapy applies the opposite force in a controlled clinical setting, and it is often described as a non-surgical alternative for back pain relief  for the right candidate.

The category includes several FDA-cleared devices on the market. The DRX9000, manufactured by Excite Medical, is one of the most clinically studied systems in the category and is used in clinics worldwide. Other systems use similar principles with different engineering approaches. At SpineWell, decompression sits inside broader non-surgical care for spine and disc conditions, not as a standalone gadget. SpineWell targets the disc, not just the pain.

The DRX9000 uses a closed-loop servo-motor traction system to elongate the spine in a controlled cycle, applying logarithmic distraction forces at angles calibrated to the affected disc level. The cyclical pulling and resting creates negative pressure within the disc space, which may encourage retraction of herniated material and improve nutrient flow into the disc.

A typical session has the patient lying comfortably on the computerized table while a precision-controlled harness applies traction. The angle of pull is calibrated to the specific lumbar level being treated (commonly L4-L5 or L5-S1, which together account for most lumbar disc herniations and sciatica cases). The force builds gradually, holds, releases partially, then builds again, in a logarithmic cycle designed to bypass the body’s natural protective muscle spasm response that would normally resist sustained traction.

The negative pressure created in the disc space (technically a reduced intradiscal pressure) can pull herniated material back toward the disc center and improve diffusion of nutrients into a tissue that has limited blood supply. The mechanism is structurally different from manual adjustment, which targets joint dysfunction, not disc pressure. You can read more about how the FDA-cleared DRX9000 spinal decompression in Jacksonville is applied in practice.

The DRX9000 holds FDA 510(k) clearance specifically for chronic low back pain and sciatica caused by lumbar herniated discs, bulging discs, degenerative disc disease, and posterior facet syndrome. These are the conditions where the clinical evidence most directly supports the protocol. This is the practical answer to what actually happens when overcoming disc herniations without surgery is the goal rather than a scalpel.

The FDA clearance is specific to lumbar applications. For these conditions, the mechanism (disc decompression) directly addresses the structural cause. Candidacy for any case is determined through imaging review (MRI is standard) and a neuro-spinal exam, not symptoms alone.

For cervical (neck) disc herniations, a related but separate device called the DRX9000C is the FDA-cleared option, manufactured by the same company. The two devices are physically and regulatorily distinct. SpineWell uses the lumbar DRX9000 for the conditions listed in its FDA clearance. For cervical or stenosis cases with a disc component contributing, related but distinct treatment approaches apply, evaluated case by case.

A typical DRX9000 session lasts 30 to 45 minutes. The patient lies fully clothed on the computerized table while a chest harness and pelvic harness apply controlled traction at the prescribed angle. Most patients describe the sensation as a gentle, painless stretching feeling, with periods of pull alternating with periods of partial release.

Many patients find the experience relaxing and some fall asleep during sessions. Music, audiobooks, or quiet rest are typical. The traction force is calibrated to the patient’s body weight and condition, with a starting protocol that is gentler in the first sessions and progressively reaches the prescribed therapeutic force over the first week.

After each session, light walking is encouraged to support circulation. Patients typically resume normal activity immediately, with specific instructions to avoid heavy lifting, prolonged sitting, or aggravating positions for the duration of the treatment cycle. There is no recovery time required between sessions, and many patients schedule appointments around work without disruption.

A standard DRX9000 protocol runs 20 to 28 sessions over six to eight weeks, with most patients attending four to five sessions per week initially. The frequency gradually decreases as the disc and surrounding tissues respond and stabilize.

The protocol length reflects the clinical observation that disc tissue takes weeks to respond to sustained decompression, with measurable changes typically appearing in the third to fourth week for responsive patients. Earlier than that, symptoms may improve due to inflammation reduction, but structural changes within the disc itself take longer.

Some severe or chronic cases require extended protocols beyond 28 sessions. Less complex cases may show meaningful improvement in fewer. The specific protocol is set after the initial evaluation, including imaging review, and adjusted based on how the patient responds during the first two weeks of treatment.

Some severe or chronic cases require extended protocols beyond 28 sessions. Less complex cases may show meaningful improvement in fewer. The specific protocol is set after the initial evaluation, including imaging review, and adjusted based on how the patient responds during the first two weeks of treatment.

Candidacy is determined by imaging review and a specialist exam. Strong candidates have MRI-confirmed lumbar disc herniation, bulging disc, or degenerative disc disease with corresponding symptoms. Contraindications include severe spinal stenosis with neurological signs, certain fusion hardware, advanced osteoporosis, certain tumors, recent spinal fractures, and pregnancy. If you are still deciding who to consult, this guide on the best doctor for a herniated disc in Jacksonville is a useful starting point.

A candidate evaluation typically includes imaging review (MRI is standard for confirming the disc problem), neuro-spinal examination (reflexes, sensation, strength), assessment of overall spine health, and a candid conversation about whether decompression is the right intervention given the patient’s specific case.

Not every patient with back pain is a DRX9000 candidate. Patients with mechanical back pain unrelated to disc compression, pure facet joint dysfunction without disc involvement, or pain from non-spinal causes (sacroiliac dysfunction, muscular strain) usually do better with other approaches. A clinic that recommends decompression without imaging review and an exam first is treating volume, not the case. Injections treat the symptom. SpineWell treats the source, which is why the evaluation comes before any protocol.

The DRX9000 differs from manual traction and basic decompression tables in three ways: it uses computer-controlled servo-motor technology for precise force calibration, it applies logarithmic distraction forces (not constant tension), and it targets specific spinal levels through angle adjustment. Manual traction lacks all three of these elements.

Manual traction is a useful technique in chiropractic and physical therapy, but it applies general lengthening force across the spine without level-specific targeting. Basic decompression tables sometimes found in gyms or chiropractic offices apply traction but without the closed-loop feedback that ensures the patient stays within the prescribed therapeutic range.

The closed-loop servo system means that if the patient’s muscles begin to resist (a natural protective response), the DRX9000 automatically adjusts to maintain the prescribed therapeutic force without triggering muscle spasm. This is the technical reason the device is classified differently by the FDA from other traction equipment. The clinical category and the specific equipment are not the same thing, which is why FDA clearance is important when choosing a clinic.